Waters receives CE Mark for MassTrak vitamin D solution

Waters' fully-validated MassTrak vitamin D solution has received European CE Mark approval for use as an in vitro diagnostic tool.

Designed for the quantitative measurement of 25(OH) D2 and D3 (25-OH-VitD) from human plasma and serum, the solution consists of reagents and consumables, instrumentation and software and support services for clinical laboratories that routinely measure vitamin D levels.

It is the first single-vendor system capable of measuring both vitamins 25(OH) D2 and D3 independently and accurately from human plasma and serum in a single analysis, and is designed for use with Waters' Acquity UPLC I-Class and Xevo TQD IVD systems, MassTrak vitamin D kit and MassLynx mass spectrometry software.

Dr Jose Castro-Perez, director of health sciences and global marketing operations at Waters, said: "It's the ideal solution for clinical laboratories performing (25-OH-VitD) analysis on a routine basis and which may want to standardise (25-OH-VitD) analysis on a single-vendor platform."

Vitamin D plays a key role in preserving bone strength, while it also plays a role in modulating cell growth, the function of neuromuscular and immune systems, and reducing inflammation. As such, monitoring vitamin D levels is an essential element of human health management.

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.